Clinical trial
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With…
NCT00141336 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141336 |
|---|---|
| Title | To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. |
| Official title | Pregabalin BID Open-Label Add-On Trial: An Open-Label, Multicenter Follow-On Study to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Seizure Disorder, Partial |
| Intervention type | Drug |
| Interventions | Pregabalin |
| Enrollment | 750 |
| Start date | Nov 1, 1999 |
| Completion | Jul 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Jan 1, 2007 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: